Scopolamine (Nobelpharma)

N/A

Report date: 2025/05/15 20:00:08

Base Information

Drug NameScopolamine (Nobelpharma)
Drug Alias NameNPC-22
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNobelpharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNobelpharma Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A